1. Home
  2. NXL vs IZEA Comparison

NXL vs IZEA Comparison

Compare NXL & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • IZEA
  • Stock Information
  • Founded
  • NXL 2010
  • IZEA 2006
  • Country
  • NXL United States
  • IZEA United States
  • Employees
  • NXL N/A
  • IZEA N/A
  • Industry
  • NXL Medical Specialities
  • IZEA Advertising
  • Sector
  • NXL Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • NXL Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • NXL 31.1M
  • IZEA 29.8M
  • IPO Year
  • NXL 2022
  • IZEA N/A
  • Fundamental
  • Price
  • NXL $1.69
  • IZEA $1.75
  • Analyst Decision
  • NXL Strong Buy
  • IZEA
  • Analyst Count
  • NXL 1
  • IZEA 0
  • Target Price
  • NXL $5.00
  • IZEA N/A
  • AVG Volume (30 Days)
  • NXL 117.5K
  • IZEA 32.2K
  • Earning Date
  • NXL 05-09-2025
  • IZEA 05-14-2025
  • Dividend Yield
  • NXL N/A
  • IZEA N/A
  • EPS Growth
  • NXL N/A
  • IZEA N/A
  • EPS
  • NXL N/A
  • IZEA N/A
  • Revenue
  • NXL $168,721.00
  • IZEA $35,881,010.00
  • Revenue This Year
  • NXL $79.59
  • IZEA $22.24
  • Revenue Next Year
  • NXL $334.65
  • IZEA N/A
  • P/E Ratio
  • NXL N/A
  • IZEA N/A
  • Revenue Growth
  • NXL 52.35
  • IZEA N/A
  • 52 Week Low
  • NXL $0.53
  • IZEA $1.68
  • 52 Week High
  • NXL $4.49
  • IZEA $3.60
  • Technical
  • Relative Strength Index (RSI)
  • NXL 37.97
  • IZEA 26.17
  • Support Level
  • NXL $1.56
  • IZEA $1.68
  • Resistance Level
  • NXL $2.31
  • IZEA $1.80
  • Average True Range (ATR)
  • NXL 0.23
  • IZEA 0.10
  • MACD
  • NXL 0.01
  • IZEA -0.01
  • Stochastic Oscillator
  • NXL 24.27
  • IZEA 14.29

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: